Panacea Biotec Inks Pact with UNICEF for Supply of Pentavalent Vaccine (Easyfive-TT) in the Current Year; Receives Approval from the US Health Regulator to Market Generic Version Maxalt-MLT Tablets
Besides, the company has received approval from the US health regulator to market a generic version of Merck & Co's Maxalt-MLT tablets, used in treating migraine, in the American market. The company has received approval from the US Food and Drug Administration (USFDA) to market its generic product to treat migraine in strengths of 5 and 10 mg. The company recently got approval for its anti-cancer formulation facility from USFDA in November 2016.